Literature DB >> 2225310

Cellular glutathione as a protective agent against 4-hydroperoxycyclophosphamide cytotoxicity in K-562 cells.

R H Peters1, K Ballard, J E Oatis, D J Jollow, R K Stuart.   

Abstract

Exposure of cells of the K-562 erythroleukemia cell line to 4-hydroperoxycyclophosphamide (4-HC), an analog of activated cyclophosphamide, causes a concentration-dependent inhibition of in vitro colony formation by these cells. For investigation of the role of glutathione (GSH) in the metabolism of 4-HC, GSH levels of K-562 cells were modulated by exposing the cells to buthionine sulfoximine (BSO), a specific inhibitor of GSH synthesis, and/or to GSH ethyl esters. Both the mono- and diethyl esters of GSH were synthesized in our laboratories and their identities were determined by chromatographic methods and fast-atom-bombardment mass spectrometry. An HPLC method including electrochemical detection used for thiol determination was applied for the measurement of GSH esters. Incubation of the cells with BSO depleted GSH levels to approximately 11% of control values and potentiated the cytotoxicity of 4-HC. By contrast, exposure to GSH esters approximately doubled GSH levels and protected the cells against the toxicity of 4-HC. Moreover, when cellular GSH levels were first depleted by BSO exposure and then replenished by incubation with GSH esters, the BSO-associated potentiation of 4-HC cytotoxicity was abolished. The work described herein extends the application of an HPLC method used for thiol determination to the measurement of GSH ethyl esters. In addition, it established that GSH acts as a competitive protecting agent against the in vitro toxicity of 4-HC in the K-562 cell line.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2225310     DOI: 10.1007/bf02994088

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  32 in total

1.  Potent and specific inhibition of glutathione synthesis by buthionine sulfoximine (S-n-butyl homocysteine sulfoximine).

Authors:  O W Griffith; A Meister
Journal:  J Biol Chem       Date:  1979-08-25       Impact factor: 5.157

2.  Alkylating properties of phosphoramide mustard.

Authors:  M Colvin; R B Brundrett; M N Kan; I Jardine; C Fenselau
Journal:  Cancer Res       Date:  1976-03       Impact factor: 12.701

3.  Enhancement of the embryotoxicity of acrolein, but not phosphoramide mustard, by glutathione depletion in rat embryos in vitro.

Authors:  V L Slott; B F Hales
Journal:  Biochem Pharmacol       Date:  1987-06-15       Impact factor: 5.858

4.  Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.

Authors:  K Ono; D C Shrieve
Journal:  J Natl Cancer Inst       Date:  1987-10       Impact factor: 13.506

5.  Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide.

Authors:  H L Gurtoo; J H Hipkens; S D Sharma
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

6.  Deactivation of cyclophosphamide (NSC-26271) metabolites by sulfhydryl compounds.

Authors:  J Draeger; G Peter; H J Hohorst
Journal:  Cancer Treat Rep       Date:  1976-04

7.  Studies on the in vivo formation of acrolein: 3-hydroxy-propylmercapturic acid as an index of cyclophosphamide (NSC-26271) activation.

Authors:  R A Alarcon
Journal:  Cancer Treat Rep       Date:  1976-04

8.  Glutathione depletion as a determinant of sensitivity of human leukemia cells to cyclophosphamide.

Authors:  T R Crook; R L Souhami; G D Whyman; A E McLean
Journal:  Cancer Res       Date:  1986-10       Impact factor: 12.701

9.  Synthesis and preliminary antitumor evaluation of 4-(SR)-sulfido-cyclophosphamides.

Authors:  G Peter; H J Hohorst
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

10.  Purification of peptides: an efficient procedure for the separation of peptides from amino acids and salt.

Authors:  P Böhlen; F Castillo; N Ling; R Guillemin
Journal:  Int J Pept Protein Res       Date:  1980-10
View more
  1 in total

1.  Development of an assay for cellular efflux of pharmaceutically active agents and its relevance to understanding drug interactions.

Authors:  Benigno C Valdez; Moustapha Hassan; Borje S Andersson
Journal:  Exp Hematol       Date:  2017-05-04       Impact factor: 3.084

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.